{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:14:09Z","timestamp":1777497249349,"version":"3.51.4"},"reference-count":27,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CH"],"published-print":{"date-parts":[[2022,11,16]]},"abstract":"<jats:p>BACKGROUND: A significant degree of mortality and morbidity in Covid-19 is due to thromboembolic disease. Coagulopathy has been well described in critically unwell patients on ICU. There is less clear evidence regarding these changes at the time of presentation to the Emergency Department and the progression of disease over time. OBJECTIVE: We sought to investigate whether coagulation markers can predict severity and how they change over the disease course. METHODS: Patients presenting to a single University Teaching Hospital were recruited and followed up if PCR was positive. Alongside routine blood testing, Rotational Thromboelastometry (ROTEM) was performed. Outcome data was recorded for all patients, and ROTEM values were compared across outcome groups. RESULTS: Extem and Intem Maximum Lysis were significantly reduced in those who died or required an ICU admission, indicating a reduced ability to break down clot mass in the most critically unwell patients. CONCLUSION: Comparisons between groups demonstrated that one distinguishing feature between those who require ICU admission or die of Covid-19 compared with those who survive a hospital stay to discharge was the extent to which fibrinolysis could occur. Mortality and morbidity in Covid-19 infection appears in part driven by an inability to break down clot mass.<\/jats:p>","DOI":"10.3233\/ch-221491","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T12:33:07Z","timestamp":1654605187000},"page":"183-191","source":"Crossref","is-referenced-by-count":6,"title":["Impaired fibrinolysis in severe Covid-19 infection is detectable in early stages of the disease"],"prefix":"10.1177","volume":"82","author":[{"given":"Oliver","family":"Watson","sequence":"first","affiliation":[{"name":"Welsh Centre for Emergency Medicine Research, Swansea Bay University Health Board, Swansea, UK"},{"name":"Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Pillai","sequence":"additional","affiliation":[{"name":"Welsh Centre for Emergency Medicine Research, Swansea Bay University Health Board, Swansea, UK"},{"name":"Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Howard","sequence":"additional","affiliation":[{"name":"Welsh Centre for Emergency Medicine Research, Swansea Bay University Health Board, Swansea, UK"},{"name":"Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Cezar","family":"Zaldua","sequence":"additional","affiliation":[{"name":"Welsh Centre for Emergency Medicine Research, Swansea Bay University Health Board, Swansea, UK"},{"name":"Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Whitley","sequence":"additional","affiliation":[{"name":"Welsh Centre for Emergency Medicine Research, Swansea Bay University Health Board, Swansea, UK"},{"name":"Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Burgess","sequence":"additional","affiliation":[{"name":"Welsh Centre for Emergency Medicine Research, Swansea Bay University Health Board, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Welsh Centre for Emergency Medicine Research, Swansea Bay University Health Board, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Morris","sequence":"additional","affiliation":[{"name":"Cardiff Metropolitan University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip Adrian","family":"Evans","sequence":"additional","affiliation":[{"name":"Welsh Centre for Emergency Medicine Research, Swansea Bay University Health Board, Swansea, UK"},{"name":"Swansea University, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"9","key":"10.3233\/CH-221491_ref1","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","article-title":"Coagulopathy of Coronavirus Disease 2019","volume":"48","author":"Iba","year":"2020","journal-title":"Crit Care Med"},{"issue":"1","key":"10.3233\/CH-221491_ref2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13054-021-03639-w","article-title":"Timing and causes of death in severe COVID-19 patients","volume":"25","author":"de Roquetaillade","year":"2021","journal-title":"Crit Care"},{"key":"10.3233\/CH-221491_ref3","doi-asserted-by":"publisher","first-page":"m1295","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"10.3233\/CH-221491_ref4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3233\/CH-209003","article-title":"Contrast enhanced ultrasonography (CEUS) to detect abdominal microcirculatory disorders in severe cases of COVID-19 infection: First experience","volume":"74","author":"Jung","year":"2020","journal-title":"Clin Hemorheol Microcirc"},{"issue":"1","key":"10.3233\/CH-221491_ref5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12959-021-00263-0","article-title":"Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients","volume":"19","author":"Boss","year":"2021","journal-title":"Thromb J"},{"issue":"2","key":"10.3233\/CH-221491_ref6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/MBC.0000000000000971","article-title":"Derangement of the coagulation process using subclinical mark253 ers and viscoelastic measurements in critically ill patients with coronavirus disease 2019 pneumonia and non-coronavirus disease 2019 pneumonia","volume":"32","author":"Pavoni","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.3233\/CH-221491_ref7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11239-020-02312-3","article-title":"Rotational thromboelastometry results are associated with care level in COVID-19","volume":"51","author":"Almskog","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.3233\/CH-221491_ref8","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211027653"},{"issue":"2","key":"10.3233\/CH-221491_ref9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/diagnostics11020172","article-title":"The Role of TEG Analysis in Patients with COVID-19 Associated Coagulopathy: A Systematic Review","volume":"11","author":"Hartmann","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"10.3233\/CH-221491_ref10","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3390\/jcm10081740","article-title":"Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review","volume":"10","author":"Bareille","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.3233\/CH-221491_ref11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1213\/ANE.0000000000003341","article-title":"Harmful or Physiologic: Diagnosing Fibrinoysis Shutdown in a Trauma Cohort With Rotational Thromboelastometry","volume":"127","author":"Gomez-Builes","year":"2018","journal-title":"Anesth Analg"},{"key":"10.3233\/CH-221491_ref12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcrc.2017.09.183","article-title":"The effect of sepsis and septic shock on the viscoelastic properties of clot quality and mass using rotational thromboelastometry: A prospective observational study","volume":"44","author":"Davies","year":"2018","journal-title":"J Crit Care"},{"key":"10.3233\/CH-221491_ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-021-02393-4"},{"issue":"3","key":"10.3233\/CH-221491_ref14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/SHK.0000000000001635","article-title":"Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU","volume":"55","author":"Creel-Bulos","year":"2021","journal-title":"Shock"},{"issue":"2","key":"10.3233\/CH-221491_ref15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","article-title":"Fibrinolysis 276 Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection","volume":"231","author":"Wright","year":"2020","journal-title":"J Am Coll Surg"},{"key":"10.3233\/CH-221491_ref16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.thromres.2020.08.046","article-title":"Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients","volume":"196","author":"van Veenendaal","year":"2020","journal-title":"Thromb Res"},{"issue":"2","key":"10.3233\/CH-221491_ref17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11239-020-02130-7","volume":"50","author":"Pavoni","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.3233\/CH-221491_ref18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3233\/CH-201071","article-title":"D-dimer daily continuous tendency predicts the short-term prognosis for COVID-19 independently: A retrospective study from Northeast China","volume":"79","author":"Xing","year":"2021","journal-title":"Clin Hemorheol Microcirc"},{"issue":"2","key":"10.3233\/CH-221491_ref19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/CH-200978","article-title":"Elevated fibrinogen and fibrin degradation product are associated with poor outcome in COVID-19 patients: A meta-analysis","volume":"77","author":"Nugroho","year":"2021","journal-title":"Clin Hemorheol Microcirc"},{"issue":"3","key":"10.3233\/CH-221491_ref20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/CH-201002","article-title":"Cerebrovascular comorbidity, high blood levels of C-reactive protein and D-dimer are associated with disease outcomes in COVID-19 patients","volume":"77","author":"Alzoughool","year":"2021","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.3233\/CH-221491_ref22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejim.2020.09.006","article-title":"Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis","volume":"82","author":"Roncon","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.3233\/CH-221491_ref23","doi-asserted-by":"publisher","first-page":"838011","DOI":"10.3389\/fimmu.2022.838011","article-title":"NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol"},{"issue":"2","key":"10.3233\/CH-221491_ref24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s11239-020-02324-z","article-title":"Neutrophil extracellular traps and thrombosis in COVID-19","volume":"51","author":"Zuo","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"10.3233\/CH-221491_ref25","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3390\/jcm11071800","article-title":"Do Circulating Histones Represent the Missing Link among COVID-19 Infection and Multiorgan Injuries, Microvascular Coagulopathy and Systemic Hyperinflammation?","volume":"11","author":"Ligi","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"10.3233\/CH-221491_ref26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/biom11050694","article-title":"Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps","volume":"11","author":"Bautista-Becerril","year":"2021","journal-title":"Biomolecules"},{"key":"10.3233\/CH-221491_ref27","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3389\/fphar.2020.00870","article-title":"Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19","volume":"11","author":"Narasaraju","year":"2020","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.3233\/CH-221491_ref28","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/infdis\/jiab050","article-title":"High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019","volume":"223","author":"Ouwendijk","year":"2021","journal-title":"J Infect Dis"}],"container-title":["Clinical Hemorheology and Microcirculation"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CH-221491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:06:00Z","timestamp":1777388760000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CH-221491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":27,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/ch-221491","relation":{},"ISSN":["1386-0291","1875-8622"],"issn-type":[{"value":"1386-0291","type":"print"},{"value":"1875-8622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]}}}